Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate) Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) February 2016 DRUG INTERACTIONS NS5A inhibitor/NS5B polymerase inhibitor: ledipasvir/sofosbuvir Patients receiving ATRIPLA and...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts